Protease Inhibitors (PIs)
PIs, as their name suggests, work by blocking the activity of proteases. Proteases are the viral enzymes responsible for accurately cleaving newly formed viral proteins that result from translation of viral mRNA. Therefore, PIs prevent the formation of viral proteins, resulting in a paucity of available proteins for the formation of new copies of HIV.
FDA-approved PIs
For additional information about GlaxoSmithKline HIV products, please click on "Important Safety Information/Indications."
 |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
 |
*The brands listed above are trademarks of their respective owners and are not trademarks of The GlaxoSmithKline Group of Companies. The makers of these brands are not affiliated with and do not endorse GlaxoSmithKline or its products.